Together, Certara and our partners provide customers across the globe with products, services and solutions that help solve the key challenges in drug discovery and development.
Working in partnership with respected scientists at academic Centers of Excellence (COE), Certara is committed to training the next generation of experts in model-informed drug development. Our COE program is designed to:
- Research and solve PK/PD challenges
- Provide faculty, students, and researchers access to innovative software
- Lead the way from ideas to the implementation of cutting-edge technologies
- Participate in testing of technologies
Our technology & platform partners offer complementary products and platforms.
- ChemAxon: Integration between ChemAxon’s industry standard chem-informatics tools and Certara’s D360 scientific informatics platform
- CORE Informatics: Standard connector for Certara’s D360 to Core Informatics LIMS databases
- Excelra: Certara leverages Excelra’s scientific knowledge base and technology for Clinical Trials Outcomes Database updates.
- Optibrium: Connectivity between Optibrium’s multi-parameter analysis package StarDrop and Certara’s D360
- Rudraya: Certara partners with Rudraya to provide the KEEP informatics platform for our Clinical Trials Outcomes Databases.
We entered into a CRADA with the US FDA to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds.
This five-year project aims to deliver physiologically-based pharmacokinetic (PBPK) dog models to help streamline the process of veterinary drug product development and evaluation.
This will be accomplished by facilitating the use of pharmacokinetic principles to address complex questions associated with the design and interpretation of target animal safety studies and clinical field studies by enabling the integration of model predictions with data from safety and effectiveness studies.